Axsome Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 685,125 | 1.41% |
| General Public | 984,248 | 2.03% |
| Hedge Funds | 4,189,557 | 8.64% |
| Private Companies | 7,344,500 | 15.2% |
| Institutions | 35,258,946 | 72.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 7,344,500 | US$724.8m | 0% | no data | |||
| 4,189,557 | US$413.4m | -9.6% | 5.56% | |||
| 3,995,345 | US$394.3m | 6.77% | 0.01% | |||
| 3,398,379 | US$335.4m | 2.98% | 0.01% | |||
| 2,360,077 | US$232.9m | 0% | 18.62% | |||
| 1,087,665 | US$107.3m | 20.6% | 0.01% | |||
| 1,046,000 | US$103.2m | 9.53% | 2.98% | |||
| 1,000,000 | US$98.7m | 0% | 1.18% | |||
| 995,287 | US$98.2m | -7.26% | 0.11% | |||
| 916,808 | US$90.5m | -2.31% | no data | |||
| 908,459 | US$89.6m | 2.66% | 0.01% | |||
| 857,219 | US$84.6m | -53.7% | 2.54% | |||
| 827,887 | US$81.7m | -11.8% | 1.36% | |||
| 782,844 | US$77.3m | 70.5% | 1.67% | |||
| 742,745 | US$73.3m | 1.11% | 0.01% | |||
| 738,503 | US$72.9m | -0.32% | 52.36% | |||
| 625,084 | US$61.7m | 13.8% | 0.88% | |||
| 602,024 | US$59.4m | -21.8% | 0.02% | |||
| 581,557 | US$57.4m | 4.68% | 0.01% | |||
| 577,190 | US$57.0m | 13.1% | 0.14% | |||
| 525,000 | US$51.8m | -28.1% | 0.09% | |||
| 467,427 | US$46.1m | 0% | 2.92% | |||
| 451,866 | US$44.6m | 2,990% | no data | |||
| 404,217 | US$39.9m | 0% | no data | |||
| 400,000 | US$39.5m | 0% | 2.5% |